InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

- Current share price for RHT : $0.059

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$28 Appendix 4G & Corporate Governance Statement 31 Aug 2026 7:29PM $0.059 $0.059 fallen by 0%
$28 FY26 Full Year Results & Investor Webinar 28 Aug 2026 9:28AM $0.065 $0.059 fallen by 9.23%
$28 FY26 Full Year Results & FY27 Guidance Investor Presentation 28 Aug 2026 9:24AM $0.065 $0.059 fallen by 9.23%
$28 Appendix 4E, Full Year Statutory Accounts & Annual Report 28 Aug 2026 9:17AM $0.065 $0.059 fallen by 9.23%
$28 FY26 Full Year Results Webinar 19 Aug 2026 1:35PM $0.056 $0.059 risen by 5.36%
$28 Cessation of Quarterly Reporting 12 Aug 2026 1:41PM $0.057 $0.059 risen by 3.51%
$28 Quarterly Activities/Appendix 4C Cash Flow Report 24 Jul 2026 9:54AM $0.047 $0.059 risen by 25.53%
$28 Change of Director's Interest Notice - Simon Panton 15 Jul 2026 1:23PM $0.048 $0.059 risen by 22.92%
$28 Liver Fibrosis Device Progress & FY26 Portfolio Webinar 9 Jun 2026 9:43AM $0.040 $0.059 risen by 47.50%
$28 Change of Director's Interest Notice - Dr David Fuller 27 May 2026 8:20AM $0.039 $0.059 risen by 51.28%
$28 Profit Guidance Upgrade 5 May 2026 9:58AM $0.048 $0.059 risen by 22.92%
$28 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2026 8:51AM $0.043 $0.059 risen by 37.21%
$28 Initial Director's Interest Notice - Michael Sistenich 28 Apr 2026 9:05AM $0.044 $0.059 risen by 34.09%
$28 Initial Director's Interest Notice - Dr David Fuller 28 Apr 2026 9:03AM $0.044 $0.059 risen by 34.09%
$28 Director Appointments 28 Apr 2026 8:47AM $0.044 $0.059 risen by 34.09%
$28 Change of Director's Interest Notice - Simon Panton 1 Apr 2026 9:17AM $0.040 $0.059 risen by 47.50%
$28 Receipt of R&D Tax Incentive Refund 16 Mar 2026 2:18PM $0.039 $0.059 risen by 51.28%
$28 Application for quotation of securities - RHT 2 Mar 2026 8:15AM $0.045 $0.059 risen by 31.11%
$28 Notification regarding unquoted securities - RHT 27 Feb 2026 8:28PM $0.045 $0.059 risen by 31.11%
$28 Half Year Results Presentation 27 Feb 2026 10:14AM $0.047 $0.059 risen by 25.53%
$28 Half Year Results 27 Feb 2026 9:58AM $0.047 $0.059 risen by 25.53%
$28 Half Year Report & Accounts 27 Feb 2026 9:56AM $0.047 $0.059 risen by 25.53%
$28 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2026 9:55AM $0.043 $0.059 risen by 37.21%
$28 Change of Director's Interest Notice - Simon Panton 15 Dec 2025 9:48AM $0.046 $0.059 risen by 28.26%
$28 Application for quotation of securities - RHT 15 Dec 2025 8:19AM $0.046 $0.059 risen by 28.26%

1 - 25 of 531 results

Page 1 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.